Swiss Prime Site AG (SWX:SPSN)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
112.60
-0.10 (-0.09%)
Jul 31, 2025, 5:31 PM CET
-0.09%
Market Cap9.03B
Revenue (ttm)670.95M
Net Income (ttm)360.25M
Shares Out80.23M
EPS (ttm)4.52
PE Ratio24.93
Forward PE22.39
Dividend3.45 (3.06%)
Ex-Dividend DateMar 21, 2025
Volume156,452
Average Volume120,333
Open113.10
Previous Close112.70
Day's Range112.50 - 113.40
52-Week Range87.05 - 121.40
Beta0.44
RSI37.70
Earnings DateAug 21, 2025

About Sage Therapeutics

Swiss Prime Site AG, through its subsidiaries, operates as a real estate company in Switzerland. It operates though Real Estate, Asset management, and Retail segments. The Real Estate segment purchases, develops, sells, and leases properties. The Asset Management segment is involved in the funds, asset management, and investment advisory businesses. The Retail segment operates department stores. The company was founded in 1999 and is headquartered in Zug, Switzerland. [Read more]

Founded 1999
Employees 570
Stock Exchange SIX Swiss Exchange
Ticker Symbol SPSN
Full Company Profile

Financial Performance

In 2024, Swiss Prime Site AG's revenue was 670.95 million, an increase of 0.47% compared to the previous year's 667.78 million. Earnings were 360.25 million, an increase of 52.64%.

Financial Statements

News

There is no news available yet.